Skip to main content
NUWE
NASDAQ Industrial Applications And Services

Nuwellis Prices $3.4M Offering at $2.59/Share with Warrants — Deep Discount to Market

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$1.65
Mkt Cap
$633.873K
52W Low
$1.61
52W High
$378.347
52W Position info
2.5% above low
Off High info
100% below high
Rel. Volume info
3.0× avg
Market data snapshot near publication time

NUWE is trading near its 52-week low of $1.61 (2.5% above the low) on elevated volume (3.0× avg).

Summary

Nuwellis priced a $3.4 million public offering at $2.59 per share — a steep discount to its $4.45 last sale — with warrants for an equal number of shares, adding substantial dilution pressure to a company already fighting for survival.


Key Events · Financing and Capital Events · NUWE

  • Deeply Discounted Offering Priced

    Nuwellis is selling 1,310,890 shares at $2.59 each, a 42% discount to the July 30 closing price of $4.45, for gross proceeds of $3.4 million.

  • Warrants Double Potential Dilution

    Investors receive warrants to buy an additional 1,310,890 shares at $2.59, exercisable for five years, potentially doubling the share count if exercised.

  • Net Proceeds of ~$2.9 Million

    After a 9% placement agent fee ($305,568), a 0.85% management fee, and ~$84,000 in expenses, Nuwellis nets approximately $2.9 million for working capital.

  • Preliminary Revenue Growth Disclosed

    The prospectus supplement reveals preliminary Q2 2026 revenue growth of 14% year-over-year and 20% for the first half of 2026, but this positive news is overshadowed by the dilutive financing.


Analysis · NUWE · Industrial Applications And Services

Nuwellis is raising $3.4 million in a deeply discounted offering priced at $2.59 per share, a 42% discount to the last reported sale price of $4.45 on July 30, 2026. The deal includes warrants for an equal number of shares at the same $2.59 exercise price, doubling the potential dilution. This follows a series of distressed financings, a recent 1-for-35 reverse stock split, and a going-concern warning. The company disclosed preliminary Q2 revenue growth of 14% year-over-year, but the offering's structure signals urgent cash needs and significant dilution risk for existing shareholders.

At the time of this filing, NUWE was trading at $1.65 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $633.9K. The 52-week trading range was $1.61 to $378.35. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NUWE - Latest Insights

NUWE
Jul 31, 2026, 8:42 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $1.97
Real-time Price: $1.65 info
Change: -$0.320 (-16%) info
Market Cap: $633.873K info
NUWE
Jul 27, 2026, 8:32 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1.99
Real-time Price: $1.65 info
Change: -$0.340 (-17%) info
Market Cap: $633.873K info
NUWE
Jul 24, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.01
Real-time Price: $1.65 info
Change: -$0.3554 (-18%) info
Market Cap: $633.873K info
NUWE
Jul 07, 2026, 4:30 PM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $3.15
Real-time Price: $1.65 info
Change: -$1.50 (-48%) info
Market Cap: $633.873K info
NUWE
Jun 26, 2026, 5:11 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $4.02
Real-time Price: $1.65 info
Change: Reverse Stock Split info
Market Cap: $633.873K info